Clinical Trial Update: The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions

View source ↗

Summary

This clinical trial will evaluate the diagnostic accuracy of 18F-FDG PET with contrast-enhanced MRI for detecting malignant liver lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Snippet

Sponsor: Shanghai East Hospital | Conditions: Liver Cancer, Adult | Status: NOT_YET_RECRUITING